AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP, CFO and Treasurer David A Spellman sold $68K of Akebia Therapeutics, Inc.
Sold$67,890
$1.07Price
63,567Shares
−12%Stake
What AKBA did after the filing
- The stock from Thu, May 18 close, $1.09
- −17.2%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Jul 3 close.
Traded Tue, May 16. Filed Thu, May 18, 2:19 PM ET, during the session. Returns use the May 18 close and the Jul 3 close. Not investment advice.